379 related articles for article (PubMed ID: 32765505)
1. Efficient Induction of Cytotoxic T Cells by Viral Vector Vaccination Requires STING-Dependent DC Functions.
Barnowski C; Ciupka G; Tao R; Jin L; Busch DH; Tao S; Drexler I
Front Immunol; 2020; 11():1458. PubMed ID: 32765505
[TBL] [Abstract][Full Text] [Related]
2. Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway.
Dai P; Wang W; Cao H; Avogadri F; Dai L; Drexler I; Joyce JA; Li XD; Chen Z; Merghoub T; Shuman S; Deng L
PLoS Pathog; 2014 Apr; 10(4):e1003989. PubMed ID: 24743339
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo.
Liu L; Chavan R; Feinberg MB
BMC Immunol; 2008 Apr; 9():15. PubMed ID: 18412969
[TBL] [Abstract][Full Text] [Related]
4. Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect.
Brandler S; Lepelley A; Desdouits M; Guivel-Benhassine F; Ceccaldi PE; Lévy Y; Schwartz O; Moris A
J Virol; 2010 May; 84(10):5314-28. PubMed ID: 20219934
[TBL] [Abstract][Full Text] [Related]
5. Interference with SAMHD1 Restores Late Gene Expression of Modified Vaccinia Virus Ankara in Human Dendritic Cells and Abrogates Type I Interferon Expression.
Sliva K; Martin J; von Rhein C; Herrmann T; Weyrich A; Toda M; Schnierle BS
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462561
[TBL] [Abstract][Full Text] [Related]
6. Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.
Volz A; Langenmayer M; Jany S; Kalinke U; Sutter G
J Virol; 2014 Sep; 88(18):10946-57. PubMed ID: 25008931
[TBL] [Abstract][Full Text] [Related]
7. Activation of human dendritic cells by recombinant modified vaccinia virus Ankara vectors encoding survivin and IL-2 genes in vitro.
Tao R; Li L; Huang W; Zheng L
Hum Gene Ther; 2010 Jan; 21(1):98-108. PubMed ID: 19715401
[TBL] [Abstract][Full Text] [Related]
8. Type I Interferon Promotes Humoral Immunity in Viral Vector Vaccination.
Zhong C; Liu F; Hajnik RJ; Yao L; Chen K; Wang M; Liang Y; Sun J; Soong L; Hou W; Hu H
J Virol; 2021 Oct; 95(22):e0092521. PubMed ID: 34495698
[TBL] [Abstract][Full Text] [Related]
9. Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
Waibler Z; Anzaghe M; Ludwig H; Akira S; Weiss S; Sutter G; Kalinke U
J Virol; 2007 Nov; 81(22):12102-10. PubMed ID: 17855554
[TBL] [Abstract][Full Text] [Related]
10. Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression.
Marín MQ; Pérez P; Gómez CE; Sorzano CÓS; Esteban M; García-Arriaza J
Viruses; 2018 Aug; 10(8):. PubMed ID: 30096846
[TBL] [Abstract][Full Text] [Related]
11. Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways.
García-Arriaza J; Arnáez P; Gómez CE; Sorzano CÓ; Esteban M
PLoS One; 2013; 8(6):e66894. PubMed ID: 23826170
[TBL] [Abstract][Full Text] [Related]
12. Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.
Chahroudi A; Garber DA; Reeves P; Liu L; Kalman D; Feinberg MB
J Virol; 2006 Sep; 80(17):8469-81. PubMed ID: 16912297
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice.
Bohnen C; Wangorsch A; Schülke S; Nakajima-Adachi H; Hachimura S; Burggraf M; Süzer Y; Schwantes A; Sutter G; Waibler Z; Reese G; Toda M; Scheurer S; Vieths S
Allergy; 2013 Aug; 68(8):1021-8. PubMed ID: 23909913
[TBL] [Abstract][Full Text] [Related]
14. Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.
Guzman E; Cubillos-Zapata C; Cottingham MG; Gilbert SC; Prentice H; Charleston B; Hope JC
J Virol; 2012 May; 86(10):5452-66. PubMed ID: 22419811
[TBL] [Abstract][Full Text] [Related]
15. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
[TBL] [Abstract][Full Text] [Related]
16. Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene
Chea LS; Wyatt LS; Gangadhara S; Moss B; Amara RR
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541829
[TBL] [Abstract][Full Text] [Related]
17. Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo.
Drexler I; Antunes E; Schmitz M; Wölfel T; Huber C; Erfle V; Rieber P; Theobald M; Sutter G
Cancer Res; 1999 Oct; 59(19):4955-63. PubMed ID: 10519409
[TBL] [Abstract][Full Text] [Related]
18. Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses.
Wolferstätter M; Schweneker M; Späth M; Lukassen S; Klingenberg M; Brinkmann K; Wielert U; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
J Virol; 2014 Dec; 88(24):14396-411. PubMed ID: 25297997
[TBL] [Abstract][Full Text] [Related]
19. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine.
Ramírez JC; Gherardi MM; Esteban M
J Virol; 2000 Jan; 74(2):923-33. PubMed ID: 10623755
[TBL] [Abstract][Full Text] [Related]
20. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
